Patent · US Expired

Method of refolding human IL-13

US5596072A · kind A · utility

51Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 1993
Grant dateJan 21, 1997
Priority date
Expiry dateFeb 1, 2013

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/141
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nucleic acids encoding human IL-13, and purified IL-13 proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.